'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Mastellos, Dimitrios C. and Blom, Anna M. and Connolly, E. Sander and Daha, Mohamed R. and Geisbrecht, Brian V. and Ghebrehiwet, Berhane and Gros, Piet and Hajishengallis, George and Holers, V. Michael and Huber-Lang, Markus and Kinoshita, Taroh and Mollnes, Tom E. and Montgomery, Robert A. and Morgan, B. Paul and Nilsson, Bo and Pio, Ruben and Ricklin, Daniel and Risitano, Antonio M. and Taylor, Ronald P. and Mantovani, Alberto and Ioannidis, John P. A. and Lambris, John D.. (2019) 'Stealth' corporate innovation: an emerging threat for therapeutic drug development. Nature immunology, 20 (11). pp. 1409-1413.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/73079/

Downloads: Statistics Overview

Faculties and Departments:05 Faculty of Science > Departement Pharmazeutische Wissenschaften > Pharmazie > Molekulare Pharmazie (Ricklin)
UniBasel Contributors:Ricklin, Daniel
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:31 Aug 2020 13:24
Deposited On:31 Aug 2020 13:24

Repository Staff Only: item control page